Our editors tested two popular glucose monitors to determine which is the best for improving ​​diet, sleep and exercise habits.

Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, taking place in Barcelona from 11-14 March.

New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.

Dexcom (Nasdaq:DXCM) today announced its plans to share new data supporting its diabetes management technology at ATTD 2026.

The Stelo is available to anyone who wants to monitor their blood glucose, no prescription needed. But as an active adult without diabetes, are these extra data points worth $99 per month?

The MiniMed 780G system already has compatibility with Medtronic’s Guardian 4 and Simplera Sync sensors. Both offer up to seven days of wear. Now, with Instinct, users can more than double that sensor ...

Dexcom will stop producing G6 CGM sensors July 1, 2026, urging patients to switch to the smaller, more accurate G7 model.

Abstract: Falls represent a significant health concern, especially among the elderly and individuals with mobility impairments, often resulting in severe injuries or fatalities. Current fall detection ...

Aristotle Funds, an investment advisor, released its “Growth Equity Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equity markets reached new all-time ...

Created by our trusted partner AviaCost, get a 40,000 feet view of true operating cost. The Cirrus SR22T G7 stands out in the piston single category, offering unparalleled performance and luxury. With ...

Theranica, a neuromodulation therapeutics company advancing clinically validated, drug-free treatments for idiopathic pain conditions and setting a new standard of care in migraine with REN-based ...